Eli Lilly has strong financial incentive to make the medication accessible, because broader adoption drives revenue far more effectively than keeping prices artificially high and limiting the patient pool
J Bone Min Res Off J Am Soc Bone Min Res
Berberine is one of few supplements with human trials that support the positive health claims
Alongside Eli Lilly, Novo Nordisk NVO, Amgen AMGN and Viking Therapeutics VKTX remain key players in the obesity-drug race
Gastrointestinal side effects represent the most common adverse events associated with GLP-1 therapy, affecting 30-50% of patients to varying degrees
83 Furthermore, R1881 (synthetic androgen) increased the expression and activity of CPTI, the rate-limiting enzyme in the process of mitochondrial FAO, through AR-mediated pathway, leading to increased production of ROS associated with prostate cell proliferation and mutagenesis